Adamax 10MG

Product Overview

Adamax 10MG is a supplier-defined lyophilised research material marketed under the name Adamax, supplied as white to off-white lyophilised powder in a 10mg catalogue presentation (SKU AX10). This page describes the stated research identity and batch-oriented catalogue specification; it does not provide an administration protocol.

A reliable public primary-source record confirming the sequence, molecular formula, molecular weight or standardised scientific identity of Adamax was not identified. Product-level research claims should therefore be limited to batch documentation and analytical verification.

Identity and Specifications

• Product: Adamax 10MG
• SKU: AX10
• Format: White to off-white lyophilised powder
• Synonyms: Adamax research peptide
• Composition: Supplier-defined identity; sequence and standardised molecular identity not independently confirmed
• Catalogue purity specification: ≥99% (supplier specification)
• Amount: 10mg

Research Context

The following themes summarise published research on the named molecule or components. They are research contexts, not claims about the supplied ExtolX batch.

Areas of Research

• supplier-document verification
• identity testing by appropriate analytical methods
• purity and impurity-profile assessment
• method validation and batch comparability

Evidence Quality and Limitations

Because the underlying molecular identity is not independently confirmed, mechanism-specific or disease-related claims would be speculative. The draft deliberately omits them.

Storage and Handling

As supplied: Keep the vial sealed, dry and protected from light. Follow the supplier label, safety data and batch documentation for storage temperature and handling.

In solution: Product-specific conditions or a shelf life cannot be stated until the material’s identity, sequence, salt and formulation have been verified. Follow the supplier documentation and validate any preparation and storage conditions within the laboratory method.

Compatibility Limitations

Do not infer solubility or stability from another peptide, blend, amount or pharmaceutical formulation. Use small-scale method development and appropriate analytical controls before committing valuable material.

Laboratory Safety

Handle only in an appropriately equipped laboratory by trained personnel. Use a task-specific risk assessment, suitable personal protective equipment and applicable safety documentation. Avoid ingestion, inhalation, skin contact and environmental release, and dispose of waste in accordance with local requirements.

Sources

• Storage source: batch-specific supplier label, safety data and documentation; no adequate identity-specific public source was located.
• FDA guidance on analytical procedures and method validation

Scientific sources last reviewed: 23 August 2026.

Research Use Agreement & Disclaimer

For laboratory research use only. Not for human or veterinary use. Purchasers are responsible for lawful handling, storage and disposal in accordance with applicable regulations and good laboratory practice. Product information is educational and is not medical advice or evidence of efficacy.